What is Longevity Medicine 201?

The Longevity Medicine 201 is a pivotal curriculum that provides medical professionals with the most recent advances in biogerontology, geroscience, and precision medicine while teaching the ways to implement this knowledge in clinical practice.

Course Highlights

Longevity Medicine 201 course provides you with:

AI-narrated core lectures from experts in the field
Supplementary materials: slides and notes
References to reading materials and online resources
Quizzes to track your progress
Certificate of completion

Longevity Medicine 201 is the second course in a series intended to provide advanced physicians with the latest approaches in longevity technology.

What you'll learn

Fundamentals of aging research: terminology, key notions, theories, and hallmarks of aging
Toolkit for tracking and measuring aging: from simple biomarkers to deep aging clocks
Molecular regulatory pathways linked with longevity
Geroprotective interventions and clinically available geroprotectors
AI technology in Longevity Medicine

Course Curriculum

Getting started

Available in days

days after you enroll

Course Introduction (18:25)

What is Aging?

Available in days

days after you enroll

Longevity Pathways

Available in days

days after you enroll

Clinically available potential geroprotectors

Available in days

days after you enroll

Artificial Intelligence in Longevity Medicine

Available in days

days after you enroll

AI-Guided Longevity Medicine (2:01)

Final

Available in days

days after you enroll

Take this course for free

FREE

Free

You will be granted access to the course materials for free. You can claim a certificate of completion after you've finished the course and successfully passed the final graded test.

Course Completion Certificate

The certificate will be automatically available for print or download after successful completion of the course and passing the final assessment.

Course Authors

Alex Zhavoronkov

Alex Zhavoronkov, PhD, is the founder and Chief Longevity Officer of Deep Longevity, Inc, a global company developing a broad range of artificial intelligence-based biomarkers of aging and longevity. He is also the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery, and biomarker development.

Evelyne Bischof

Dr.Bischof is a specialist in internal medicine, with research focus on Artificial Intelligence (AI) and digital health, especially in the fields of oncology, preventative and precision medicine, biogerontology, and geronto-oncology. She is also a longevity physician at Human Longevity and board member of various internal medicine societies.

Alexey Moskalev

Prof. Alexey Moskalev is a Corresponding Member of Russian Academy of Sciences, Doctor of Biology. He is a member of the editorial boards of Ageing research reviews, Aging, Biogerontology, Frontiers in Genetics of Aging, Aging and disease, Gerontology, Advances in Gerontology.